Skip to content

Clinical trials

Phase 3 Anemia trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 3 Country / region: Belgium Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20044
20053
20063
20071
20081
20092
20101
20132
20142
20164
20181
20191
20201
20211
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated6
Active, not recruiting4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
Amgen4
Celgene4
Astellas Pharma Europe B.V.2
CTI BioPharma2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Takeda2
Astellas Pharma Global Development, Inc.1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia32
Myelodysplastic Syndromes8
Renal Insufficiency, Chronic7
Primary Myelofibrosis6
Myeloproliferative Disorders4
Bone Marrow Diseases3
Hematologic Diseases3
Anemia, Diamond-Blackfan2
Kidney Failure, Chronic2
Polycythemia Vera2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.